-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JNVD0nSnDddm9DAGvtGm2a4jHfvVz7WiX7oeCvdr7aNlW06ObSjozRdAUnhYhoDP 8OJKHyTG6PAED1MXUXK2NA== 0000922423-99-000574.txt : 19990503 0000922423-99-000574.hdr.sgml : 19990503 ACCESSION NUMBER: 0000922423-99-000574 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990430 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENTA INCORPORATED /DE/ CENTRAL INDEX KEY: 0000880643 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330326866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-42004 FILM NUMBER: 99606086 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVE STREET 2: SUITE 200 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 7818605150 MAIL ADDRESS: STREET 1: 99 HAYDEN AVE STREET 2: SUITE 200 CITY: LEXINGTON STATE: MA ZIP: 02421 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ARIES FINANCIAL SERVICES INC CENTRAL INDEX KEY: 0001007000 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE STREET 2: SUITE 1501 CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128324379 SC 13D/A 1 AMENDMENT NO. 14 TO SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDED SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 13)* Genta Incorporated ------------------ (Name of Issuer) Common Stock, par value $.001 per share --------------------------------------- (Title of Class of Securities) 372 45 M 20 7 ------------- (CUSIP Number) Paramount Capital Asset Management, Inc. c/o Lindsay A. Rosenwald, M.D. 787 Seventh Avenue New York, NY 10019 (212) 554-4300 with a copy to: David M. Tanen Monica C. Lord, Esq. Paramount Capital Asset Kramer Levin Management, Inc. Naftalis & Frankel LLP 787 Seventh Avenue 919 Third Avenue New York, NY 10019 New York, NY 10022 (212) 554-4356 (212) 715-9100 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) April 20, 1999 ------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following: | | Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d- 1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 11 Pages - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 2 of 11 Pages - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Paramount Capital Asset Management, Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |-| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY ------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 21,166,537 WITH ------------------------------------------ 9 SOLE DISPOSITIVE POWER None ------------------------------------------ 10 SHARED DISPOSITIVE POWER 21,166,537 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,166,537 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 66.9% (54.4% of the outstanding voting power)** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- ** The outstanding shares of Series D Preferred Stock of the Issuer are entitled to vote together with the holders of Common Stock on all matters submitted to a vote of stockholders of the Issuer. As of April 20, 1999, Paramount Capital Asset Management, Inc. may be deemed beneficially to own (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) 54.4% of the aggregate voting power of the Common Stock and Series D Preferred Stock outstanding. - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 3 of 11 Pages - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Aries Domestic Fund, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |-| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY ------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 7,009,767 WITH ------------------------------------------ 9 SOLE DISPOSITIVE POWER None ------------------------------------------ 10 SHARED DISPOSITIVE POWER 7,009,767 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,009,767 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 33.6% (21.0% of the outstanding voting power)** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- ** The outstanding shares of Series D Preferred Stock of the Issuer are entitled to vote together with the holders of Common Stock on all matters submitted to a vote of stockholders of the Issuer. As of April 20, 1999, the Aries Domestic Fund, L.P. may be deemed beneficially to own (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) 21.0% of the aggregate voting power of the Common Stock and Series D Preferred Stock outstanding. - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 4 of 10 Pages - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Aries Trust - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |-| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None OWNED BY ------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 14,156,770 WITH ------------------------------------------ 9 SOLE DISPOSITIVE POWER None ------------------------------------------ 10 SHARED DISPOSITIVE POWER 14,156,770 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 14,156,770 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 54.4% (39.2% of the outstanding voting power)** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* OO (see Item 2) - -------------------------------------------------------------------------------- ** The outstanding shares of Series D Preferred Stock of the Issuer are entitled to vote together with the holders of Common Stock on all matters submitted to a vote of stockholders of the Issuer. As of April 20, 1999, The Aries Trust may be deemed beneficially to own (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) 39.2% of the aggregate voting power of the Common Stock and Series D Preferred Stock outstanding. - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 5 of 10 Pages - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Lindsay A. Rosenwald, M.D. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |-| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 2,866,393** OWNED BY ------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 21,166,537 WITH ------------------------------------ 9 SOLE DISPOSITIVE POWER 2,866,393** ------------------------------------ 10 SHARED DISPOSITIVE POWER 21,166,537 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 24,032,930** - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 69.7% (57.5% of the outstanding voting power)** - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- ** The outstanding shares of Series D Preferred Stock of the Issuer are entitled to vote together with the holders of Common Stock on all matters submitted to a vote of stockholders of the Issuer. As of April 20, 1999, Lindsay A. Rosenwald, M.D. may be deemed beneficially to own (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) 57.5% of the aggregate voting power of the Common Stock and Series D Preferred Stock outstanding. SCHEDULE 13D This Amendment No. 14 amends and supplements the following items of the Reporting Persons' Statement on Schedule 13D, dated February 24, 1997, as amended to date (the "Schedule"). Item 2. Identity and Background Item 2 is hereby amended in its entirety to read as follows: (a) This statement is filed on behalf of Paramount Capital Asset Management, Inc. ("Paramount Capital"), Aries Domestic Fund, L.P. ("Aries Domestic"), The Aries Trust ("Aries Trust"), Dr. Lindsay A. Rosenwald (together with Paramount Capital, Aries Domestic and Aries Trust, the "Aries Reporting Persons" or the "Filing Persons"). See attached Exhibit AE which is a copy of their agreement in writing to file this statement jointly on behalf of each of them. The Aries Reporting Persons have made, and will continue to make, their own investment decisions. (b) The business address of Paramount Capital, Aries Domestic and Dr. Rosenwald is 787 Seventh Avenue, 48th Floor, New York, New York, 10019. The business address for Aries Trust is c/o MeesPierson (Cayman) Limited, P.O. Box 2003, British American Centre, Phase 3, Dr. Roy's Drive, George Town, Grand Cayman. (c) Dr. Rosenwald is an investment banker, venture capitalist, fund manager and sole shareholder of Paramount Capital,1 a Subchapter S corporation incorporated in the State of Delaware. Paramount Capital is the General Partner of Aries Domestic,2 a limited partnership organized under the laws of Delaware. Paramount Capital is the Investment Manager to Aries Trust,3 a Cayman Islands Trust. - -------- 1 Please see Exhibit B, filed herewith, indicating the executive officers and directors of Paramount Capital and providing information called for by Items 2-6 of this statement as to said officers and directors. Exhibit B is herein incorporated by reference. 2 Please see Exhibit C indicating the general partner of Aries Domestic and the general partner's executive officers and directors and providing information called for by Items 2-6 of this statement as to said general partners, officers and directors. Exhibit C is herein incorporated by reference. 3 Please see Exhibit D indicating the investment manager of the Aries Trust and the investment manager's executive officers and directors and providing information called for by Items 2-6 of this statement as to said investment manager and officers and directors. Exhibit D is herein incorporated by reference. Page 6 of 11 Pages (d) Dr. Rosenwald, Paramount Capital, Aries Domestic and Aries Trust and their respective officers, directors, general partners, investment managers, and trustees have not, during the five years prior to the date hereof, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) Dr. Rosenwald, Paramount Capital, Aries Domestic and Aries Trust and their respective officers, directors, general partners, investment managers, and trustees have not been, during the five years prior to the date hereof, parties to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws. (f) Dr. Rosenwald is a citizen of the United States. Item 3. Source and Amount of Funds or Other Consideration The information contained in Item 3 to the Schedule is hereby amended by adding the following: Between March 10 and April 20, 1999, Aries Trust and Aries Domestic used their respective general funds to purchase 421,900 and 256,800 shares of Common Stock (additional "Purchased Common Stock"), respectively, on the open market. Aries Trust made the following purchases: Date No. of Shares Purchase Price - ---- ------------- -------------- 3/10/99 14,000 $2.188 3/2599 33,500 $2.207 3/26/99 33,500 $2.335 3/29/99 26,300 $2.362 3/30/99 26,300 $2.433 3/31/99 26,300 $2.446 4/6/99 27,000 $2.381 4/7/99 27,000 $2.383 4/8/99 27,000 $2.398 4/9/99 27,000 $2.344 4/12/99 26,600 $2.319 4/13/99 26,600 $2.344 4/14/99 26,600 $2.266 4/15/99 26,600 $2.290 4/16/99 26,600 $2.290 4/19/99 14,000 $2.469 4/20/99 7,000 $2.438 Page 7 of 11 Pages Aries Domestic made the following purchases: Date No. of Shares Purchase Price - ---- ------------- -------------- 3/10/99 6,000 $2.188 3/2599 14,400 $2.207 3/26/99 14,400 $2.335 3/29/99 11,300 $2.362 3/30/99 11,300 $2.433 3/31/99 11,300 $2.446 4/1/99 37,600 $2.429 4/5/99 38,500 $2.406 4/6/99 11,500 $2.381 4/7/99 11,500 $2.383 4/8/99 11,500 $2.398 4/9/99 11,500 $2.344 4/12/99 11,400 $2.319 4/13/99 11,400 $2.344 4/14/99 11,400 $2.266 4/15/99 11,400 $2.290 4/16/99 11,400 $2.290 4/19/99 6,000 $2.469 4/20/99 3,000 $2.438 Item 5. Interest in Securities of Issuer. The information contained in Item 5 to the Schedule is hereby amended and supplemented to read as follows: (a) As of April 20, 1999: Dr. Rosenwald, as the sole shareholder of Paramount Capital and as the holder of Placement Warrants and Advisory Warrants, may be deemed beneficially to own 24,032,930 shares or 69.7% of the Issuer's Common Stock; and Paramount Capital, through the acquisitions of securities by Aries Trust and Aries Domestic, may be deemed beneficially to own 21,166,537 shares or 66.9% of the Issuer's Common Stock. Aries Domestic, Aries Trust and Hawkins may be deemed beneficially to own the following numbers of shares of Common Stock: Aries Domestic 7,009,767 Aries Trust 14,156,770 Pursuant to Rule 13d-4 promulgated under the Securities Exchange Act of 1934, as amended, the Filing Persons disclaim beneficial ownership of all the Common Stock except the Purchased Common Stock. Pursuant to Page 8 of 11 Pages Rule 13d-4 promulgated under the Securities Exchange Act of 1934, as amended, the Filing Persons each disclaim beneficial ownership of the securities held by each other. The outstanding shares of Series D Preferred Stock of the Issuer are entitled to vote together with the holders of Common Stock on all matters submitted to a vote of stockholders of the Issuer. As of April 20, 1999, Dr. Rosenwald, Paramount Capital and Aries Trust may be deemed beneficially to own (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) 57.5%, 54.4% and 39.2%, respectively, of the aggregate voting power of the Common Stock and Series D Preferred Stock outstanding. (b) Dr. Rosenwald and Paramount Capital share the power to vote or to direct the vote and to dispose or to direct the disposition of those shares owned by each of Aries Domestic and Aries Trust. Dr. Rosenwald has the sole power to vote or to direct the vote and to dispose or to direct the disposition of the shares underlying the Placement Warrants and Advisory Warrants held by him. (c) Other than certain of the open market purchases of Common Stock reported in Item 3, the Filing Persons have not engaged in any transactions in the Common Stock of the Issuer in the past 60 days. (d)&(e) Not applicable. Item 7. Material to be Filed as Exhibits. Exhibit AE: Agreement of Joint Filing of Schedule 13D dated as of April 29, 1999. Page 9 of 11 Pages SIGNATURES ---------- After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certify that the information set forth in this statement is true, complete and correct. PARAMOUNT CAPITAL ASSET MANAGEMENT, INC. Dated: April 29, 1999 New York, NY By: /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND, L.P. By: Paramount Capital Asset Management, Inc. General Partner Dated: April 29, 1999 New York, NY By: /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Chairman THE ARIES TRUST By: Paramount Capital Asset Management, Inc. Investment Manager Dated: April 29, 1999 New York, NY By: /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Chairman Dated: April 29, 1999 New York, NY /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Page 10 of 11 Pages EXHIBIT AE ---------- AGREEMENT JOINT FILING OF SCHEDULE 13D The undersigned hereby agree jointly to prepare and file with regulatory authorities a Schedule 13D and any future amendments thereto reporting each of the undersigned's ownership of securities of Genta Incorporated and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned. PARAMOUNT CAPITAL ASSET MANAGEMENT, INC. Dated: April 29, 1999 New York, NY By: /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND, L.P. By: Paramount Capital Asset Management, Inc. General Partner Dated: April 29, 1999 New York, NY By: /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Chairman THE ARIES TRUST By: Paramount Capital Asset Management, Inc. Investment Manager Dated: April 29, 1999 New York, NY By: /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Chairman Dated: April 29, 1999 New York, NY /s/ Lindsay A. Rosenwald, M.D. --------------------------------------- Lindsay A. Rosenwald, M.D. Page 11 of 11 Pages -----END PRIVACY-ENHANCED MESSAGE-----